Skip to main content

Workplace ART programmes: Why do companies invest in them and are they working?

Buy Article:

$43.63 plus tax (Refund Policy)

Abstract:

Prevalence data indicates that certain sectors within the private sector are particularly affected by HIV/AIDS. Companies in southern Africa began implementing treatment programmes in early 2002 as the corporate sector came to realise the financial imperative of offsetting employee morbidity and mortality. This article sets about to explain the rationale behind antiretroviral treatment (ART) programmes within the private sector while uncovering some of the obstacles businesses face when treating HIV-infected employees. Data suggest that in many cases employees' uptake of voluntary counselling and testing (VCT) and ART are slow. At this early stage of workplace treatment provision, data indicate that employers must seek ways to increase uptake of VCT and treatment in an attempt to make programmes more cost-effective.

Keywords: AFRICA; ARVS; COST-EFFECTIVENESS; HIV/AIDS; PRIVATE SECTOR; PROGRAMME PLANNING AND MANAGEMENT; VCT

Document Type: Research Article

Publication date: September 1, 2006

More about this publication?
  • Co-Published by NISC and Routledge - Subscriber access available here
routledg/ajar/2006/00000005/00000002/art00009
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more